Olof Ståhl
21 – 30 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment
(
- Contribution to journal › Article
- 2016
-
Mark
The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway
(
- Contribution to journal › Article
-
Mark
Characteristics of the Offspring of Women with a History of Malignancy, Excluding Congenital Malformations
(
- Contribution to journal › Article
-
Mark
Deliveries after malignant disease before pregnancy : Maternal characteristics, pregnancy, and delivery complications
(
- Contribution to journal › Article
-
Mark
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy : A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
(
- Contribution to journal › Article
- 2015
-
Mark
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols
(
- Contribution to journal › Article
-
Mark
Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience
(
- Contribution to journal › Scientific review
- 2014
-
Mark
One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
(
- Contribution to journal › Article
-
Mark
Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer.
(
- Contribution to journal › Article